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CHAPTER-1 
BIBLIOMETRICS 
INTRODUCTION 
Bibliometrics is of recent origin and relatively a new development. 
Bibliometrics is that branch of information science, which lies between the 
border of the social and physical sciences. Bibliometrics is a systematic and 
quantitative study of various phenomena of literature on a particular topic and 
the Bibliometric study helps to identify the various peculiarities of publication, 
authorship, bibliographic control, values of literature, citation and secondary 
journal coverage with the objective of getting an insight into the dynamic of the 
exposition of knowledge. Bibliometrics is a systematic formula of literature 
study, by the help of Bibliometric study, any literature can be searched in 
minimum possible time. Today, increase in the number of publications may 
have been due to the use of Bibliometric techniques in various disciplines and 
to the greater interest in the theory of literature structure. This consequently 
leads to better all organization of information resources, which is essential for 
more effective and better use. 
Bibliometrics today has become sophisticated and complex and has 
national, international and interdisciplinary quality. A. Lawani says, 
"Bibliometrics has clearly become established as a sub discipline with 
application in the history and sociology of knowledge in communication and 
information science". 
-Jjiofiotn e/ri'cs 
1.1 ORIGIN AND HISTORY OF THE TERM BIBLIOMETRICS 
The British Librarian, Alan Pritchard was credited with introducing the 
term "Bibliometrics in 1969 to replace the term statistical bibliography". Its 
usage can be traced back to the second decade of this century, a pioneer and 
good example is of a Bibliometric study conducted by 'Cole and Eales'^ in 
1917. They conducted a Statistical Analysis of the literature of comparative 
anatomy from 1543 to 1860 by counting the number of titles from both books 
and articles, and grouping them by countries of origin with periods. 
Hulme^ was the first to use the expression term 'Statistical Bibliography' 
in 1923 and later this term was used by many persons. Gross and Gross^ study 
is considered to be the third study in the field based on citations. After Huime, 
the statistical bibliography was used by Henkle^ in 1930 in his article. 'The 
periodical literature of Biochemistry" and Gosnell^ in his dissertation in 1943, 
and later in his article of 1944. Later Fusseler^ in 1948 and 1949. Raising^ in 
1962, Baker in 1966 and Pritchard® in 1968 and 1969 have used the term 
'Statistical Bibliography" in their works. 
The most prominent was of Bradford in 1934 on the distribution of 
papers among journals in Applied Geophysics and in Lubrication Research. It 
formed the back bone of the theoretical foundation of the Bibliometric study, 
known as "Bradford's Law of Scattering". 
1.2 OTHER ANALOGOUS TERMS 
Many scientists have used the term under different names like 'Libra 
metrics' 'Scientometrics' and 'Informetrics' are also use in the literature 
Bibliometrics is analogous to Ranganathan's^ 'Librametrics' in 1948. Russian 
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concepts 'Scientometrics' FID's Informetrics and some other well established 
subdisciplines like 'Econometrics', 'Psychometrics', 'Sociometrics', 'Biometries', 
'Technometrics', 'Chemometrics', 'Cliometrics', where mathematical and 
statistical calculus have been systematically applied to study and solve 
problems in their respective field. In modern times the term scientometrics is 
used for the application of quantitative methods to the history of science and 
obviously overlaps with Bibliometrics to a considerable extent. Kopeloeck 
points out during the period 1969-1977, altogether 52 different terms have been 
coined to design Bibliometrics. 
1.3 DEFINITIONS OF DIFFERENT ANALOGOUS TERM 
Bibliometrics is just one of the many sciences whose name ends with 
metrics. Many scientists have used the term under different names, but the 
concepts were more or less same. There are some well-established sub 
disciplines like, scientometrics, Informetrics, Econometrics etc. 
• Librametrics 
The terms "Librametry" historically appeared first in 1948. Indian library 
scientist S.R. Ranganathan suggested it. Under this term, he suggested using 
of mathematical and statistical method for analyzing library activities and library 
resources. However, this term did not take its place in library science and was 
forgotten for many years. Later it was called Librametrics. 
• Scientometrics 
In 1969, the term 'Scientometrics' was suggested by two Russians 
named Nalmove and Z. Mulchinko in their book "Scientometrics: The 
investigation of science as development of information process". According to 
(D 
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them scientometrics is a complex of quantitative methods, which are used to 
investigate the processes of science. 
• Informetrics 
The FID'S term 'Informetrics' was suggested by German scientists A. 
Blacker! and S.Z. Zygel in 1982 as a newly formed branch of science using 
mathematical level and practical information activities. 
• Webometrics or Cybermetrics 
Recently a new growth area in Bibliometricshas been in the emerging in 
the fieldof webometric or cybermetric as it is in often called webometrics can be 
defined as using of bibliometrics techniques in order to study the relationship of 
different site on world wide web such techniques may also be used to map out 
called "Scientific Mapping" in the traditional Bibliometric research area of the 
web. The other well established sub disciplines are like econometric. 
Psychometrics. Soclometrics and Biometrics. 
1.4 BIBLIOMETRICS: MEANING AND DEFINITIONS 
The word 'Bibliometrics' is coined by two words (i) Biblio and (ii) Metrics. 
The word biblio is derived from the combination of Latin and Greek word bibiion 
meaning book or document, on the other hand, the word metrics indicates the 
science of metre, i.e., measurement and is also derived either from the Latin or 
Greek word metrics or "Metrikos" each meaning measurement. Accordingly, 
Pritchard defined Bibliometrics as "the application of mathematical and 
statistical methods to books and other media of communications". 
There are a number of definitions of Bibliometrics given by different 
researchers such as Hulme^°, Raising", Fairthource^^ Schrade^^^ Sengupta'^ 
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and others. Howevers, a more elaborative concept of Bibliometrics has recently 
been expounded by Egghe^^ who defines "as the development and application 
of mathematical models and techniques to all aspects of communication 
(including libraries, documentation and information center, science policy)". 
• DEFINITIONS 
The following definitions have been given by various eminent peoples: 
Wyndham E. Hulme^ ^ 
"The purpose of statistical bibliography is to shed light on the process of 
written communication and of the nature and course of development of a 
discipline by means of counting and analysis of its various facts of written 
communication". 
D.T. Hawkins" 
"The quantitative analysis of the bibliographic features of a body of 
literature. 
W.S. Potter^ ^ 
"Bibliometrics is the study and measurement of the publication pattern 
of the forms of written communication and their authorship". 
Alwln M. Schrader^ ^ 
"Bibliometrics is the scientific study of recorded discourse." 
I.N. Sengupta^° 
"The organization classification and quantitative evaluation of 
publication pattern of all macro and micro-communications along with their 
authorship by mathematical and statistical calclus". 
(D 
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A. Pritchard (1968)^ ^ 
Bibliometrics is defined as, "The application of matliematical metiiods to 
books and other media of communication." 
R.A. Fairtharhe(1969p 
The definition given by him is that, "It is the Quantitative treatment of 
properties of recorded discourse and behaviour appertaining to it." 
British Standard institute (BSI): 
"The study of the use of documents and patterns of publication in which 
mathematical and statistical methods have been applied." 
Miles. L. Raising (1962p 
According to "The assembling and interpretation of statistics relating to 
books and periodicals to demonstrate historical movements to determine 
national and universal research, use of books and journals and to ascertain in 
many local situations the general use of books and journals." 
These definitions show that Bibliometrics aims at the examination of the 
statistical distribution of the processes relating to: 
(i) The utilization of documents 
(ii) Library staff, and 
(iii) Library users 
It helps to evaluate information processes and information handling in 
libraries and information centers. 
(D 
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1.5 BIBLIOMETRICS : SCOPE AND PURPOSE 
Bibliometirc studies are generally based on quantitative measurements 
without any quantitative evaluation. They are, therefore, considered only as 
partial indicators of scientific progress. 
1. It sheds light on the process of written communication and on the nature 
and course of development by a descriptive means of counting and 
analyzing the various facts of written communication. 
2. It provides infonnation about the structure of knowledge and how it is 
communicated. 
3. The scope of Bibliometrics includes studying the relationship with in a 
literature (citation studies) or describing a literature. Typically, these 
descriptions focus on consistent patterns involving authors monographs, 
journals or subject/languages. 
4. It is a quantitative science and it is divided into two basic categories: 
(a) Descriptive Bibliometrics (productivity count) 
(i) Geographic 
(ii) time period, and 
(iii) disciplines 
(b) Evaluative Biblimetrics (Literature usage count) 
or 
(i) reference count and 
(ii) citation count. 
The descriptive Bibliometrics further includes the study of the number of 
publication in a given filed or productivity of literature in the field for the purpose 
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of comparing the amount of production during different periods, or the amount 
produced in a count of papers, books and other writings in the field or often by 
a count of these writings which have abstracted in specialized abstracting 
journals. 
Evaluative Bibliometrics includes the study of literature used by research 
worker in a given field. Such a study is often made by countries the references 
cited by a large number of research workers in their papers. 
1.6 UTILITY OF BIBLIOMETRICS IN RESEARCH 
At present, bibliometric work often provides the background for more 
practical task. It is an established technique covering wide area of knowledge. 
It has, therefore, been able to involve scholars from many of these disciplines. 
Consequently, it has attracted scholars from different disciplines or their 
respective fields. Day by day, it is attaining sophistication and complexity 
having national, international and interdisciplinary character. It has established 
itself as viable and distinctive research technique for studying science of 
science based on bibliographic data. As a matter of fact, its backbone lies in its 
sound theoritical foundation most efficiently and effectively laid by some 
pioneers like Gross, Lotka, Bradford, Zipf, Derek J. de., Salla Price, Boo kstein, 
Massa vesik. Gale Brother, Pritchard, Garfield, Hulme, Fairthome and many 
others who are all not basically librarians, but belong to different branches of 
knowledge. 
The techniques evolved by these pioneers are capable of throwing light 
to various complicated problems faced by many while handling information to 
quantify the process of written communication. It has established itself as a 
(D 
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viable and distinctive measurement of human knowledge Data analysis both of 
citations and of volume of publications year by year can be useful in planning of 
retrospective bibliographies. 
Bibliometrics also provided information about the structure of knowledge. 
Its classification studies gives information about the subject language and 
country relationship, which is based on literary warrant. Bibliometrics is very 
useful in any field of research or in any discipline or it can be used in small and 
manageable ways by individuals, to improve some part of library or information 
science. 
1.7 BIBLIOMETRIC LAWS 
There are three fundamental laws which laid the formation of 
Bibliometrics are: 
1) Bordford's law of scattering of scientific papers. 
2) Lotka's Inverse square Laws of scientific Productivity. 
3) Zipf s law of Word occurrence; and 
1.7.1 Bradford's Law of Scattering 
This law was developed by 'Samuel Clement Bradford' in 1934, another 
pioneer of Bibliometrics, should be considered for his classic paper "Sources of 
Information on specific Subjects," which is the first paper published on 
observations on scattering Bradford examined two bibliographies prepared in 
the science library (Britain) on Applied Geophysics (1928-31) and Lubrication 
(1931-32) and he prepared lists of journals arranged by decreasing order of 
sources items contributed by the journals to the bibliographies. He noticed that 
in each subject there were a few very productive sources, large number of 
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sources which were moderately productive and still a large number of sources 
of constantly diminishing productivity. The whole range of periodicals were thus 
seen as "a family of successive generations of diminishing kinship, each 
generation being greater in number, than the preceding and each constituents 
of generation producing inversely according to its degree of remoteness". 
In the list of periodicals ranked by diminishing productivity, Bradford 
identified three groups of periodicals that produced approximately the same 
number of articles on the subjects, but the number of periodicals in these three 
equiproductive zones increased by a constant factor. Based on this he stated in 
his law as follows: 
"If scientific periodicals are arranged in order of decreasing productivity 
of articles on a given subject that may be divided into a nucleus of periodicals 
more particularly devoted to the subject & several groups or zones containing 
the same number of articles as the nucleus when the number of periodicals in 
nucleus and succeeding zones will be as: 
1 : n : n^  
Bradford also plotted graphs of the cumulative number of sources items 
R (n) versus the logarithm of the cumulative number of journals (log n). The 
resulting graphs for applied Geophysics and Lubrication were similar to the 
graph shown in 1.7.1.1 such a graph, is sometimes called as Bradford 
bibliograph. 
The graph begins as a rising curve AP, and then continues as a straight 
line. The rising part of the graph represents the nucleus of highly productive 
joumals. The points Pi. P2 and P3 on the bibliograph are the boundaries of 
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three equioproductive zones in which the same number of articles as the 
nucleus (represented by OYI = Y1Y2 = Y2Y3) derived from an increasingly 
large number of journals (represented by 0X1, X1, X2 and X2, X3). The law 
attracted the attention of many researchers in the field and has been the main 
topic of many articles In the literature. 
Refinement of the law 
It was Vickery who first took a closer look at Bradford's formulation and 
clarified some of the obscurities. He found certain discrepancy between the 
verbal and the graphical representations. The mathematical expression was 
restarted by Vickery as follows: 
T2: (Tax- Tx): (Tax - Tax):: 1: n : n^  
When, Tx, Tax etc are related in this way, we are told, the plot of R 
against T is not a single line. Thus the above expression come closer to the 
graphical expression of Bradford. Vickery also simplified the technique of 
deriving the ratio of a. He pointed out that the law should apply not only to three 
zones but, with suitably modified values of the ratio a, to any number of zones. 
1.7.1.1 Applications of Bradford's Law 
Bradford's law provides an objective means determining zones of 
relative richness or value to a given kind of library collection. This has 
implication to the acquisition process in a library. A library can safely stock the 
journals which belong to the core or nuclear zone. It is advisable to extent the 
purchase list to the next zone till the budget limits permit. If at all the budget is 
elastic, a point will be reached at which it would be desirable to obtain copies of 
articles in the journals on demand rather than subscribing to the journals. 
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1.7.1.1 BRADFORD'S BIBLIOGRAPH 
Y3 
(0 
0) 
5 
\ 
0) 
E 
3 
ffi 
_2 
3 E 
3 o 
Y, 
Yi 
O 
Xi X3 
Log (n) 
® 
USiBfiomeirics 
Brookes is of the view that if the total expenditure on periodical provision 
is limited to the fraction 'f of the sum needed to cover the subject completely 
the buying of periodicals may be supplemented by the buying of photocopies of 
the relatively few relevant papers published in the peripheral periodicals. 
While preparing bibliographies of the journals that are to be scanned, the 
problem of their coverage are to be faced. Bradford's distribution can be 
fruitfully used to estimated the total size of a bibliography and the periodicals 
that should necessarily be included in the list of items to be covered. 
1.7.2 Lotka's Inverse Square law of Scientific Productivity 
In 1926, Alfred J. Lotka proposed his Inverse square law correlating 
contributors of scientific papers to their number of contributions. His law 
provided fundamental theoretical base for Bibliometric studies involving 
authroship. He was interested in determining "the part which men of different 
caliber contribute to the progress of science" For this, he checked the 
decemnial index of 'Chemical Abstracts 1907-1916 and counted the number of 
names against which appeared 1,2,3, etc. entries. He tabulated the data for 
6.891 names, beginning with letter 'A' and 'B' similarly the data from the 
Auerbach's Geschioetftafein dar Physic was also collected for the 1325 
physicits. Lotka then plotted the graph on a Logarithmic scale, the number of 
authors against the number of contributions made by each author and he found 
that in each case the point were closely scattered about a straight line, having a 
slope of approximately two to one. On the basis of these data, Lotka deduced a 
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general equation, for the relation between the frequency 'Y' of persons making 
'X' contributions as follows 
X" Y = Constant 
and for the special case n = 2, the constant Is 0.6079. Further he 
summarized the results as follows: 
"In the case examined It is found that the number of persons making 2 
contributions in about one fourth of those making one contribution, the number 
of making of all contributions is about 60 percent". 
In order words, for every 100 authors contributing one articles, 25 will 
contribute two articles, about 11 will contribute 3 articles and 6 will contribute 4 
articles and 50 on. 
1.7.3 Zipfs Law of Word Occurrence 
Zipf developed and extended an empirical law as observed by 
Estoup, governing a relation between the rank of word and the frequency of its 
appearance in a long text. If 'y' is the rank of a word and 'f is the frequency, 
then mathematically Zipfs law can be stand as follows: 
rc(.1/f 
fo(-1/r 
fr = C 
where 'C is a constant 
His law states that in a long textual matter if words are arranged in their 
order of frequency then the rank of any given word of the text will be inversely 
proportional to the frequency of occurrence of the word. 
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Example: in any textual part, certain words are pidced up. 
Ward 
Tiie 
An 
A 
To 
Was 
Rank (R) 
1 
2 
3 
4 
5 
Frequency 
245 
136 
100 
81 
85 
F X r 
245 
272 
300 
324 
425 
• Some Other Empirical Laws 
(1) Price;s square Root law of Scientific Productivity 
(ii) Garfiled tall<ed about the number of journals. 
(iii) Sengupta's law of Bibliometrics. 
Price's Square Root Law of Scientific Productivity 
Derek De Solla price square root law is not mathematically represented 
as Lotka's law Price in 1963 stated that "half of the scientific papers are 
contributed by the square root of total number of scientific authors" 
Garfield's Law of Concentration 
Garfield enuciated law in 1971 which is known as Garfield's law of 
concentration. Garfield in his law predicts "A basic concentration of journals in 
the common core on Nucleus of all the field." 
Sengupta's Law of Bibliometrics 
This law has been put fonward by Sengupta in 1973. This is basically an 
extension of Bradford's Law. It states that "during phases of rapid growth of 
knowledge in a scientific discipline, articles of interest to that discipline appear 
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in increasing number of periodicals distant from tlie field." Mathematically 
Sengupta's Law stands in the following form. 
F (x + y) = a + b Log (x + y) 
where f (x+y) is the cumulative number of references as contained in the 
first (x+y) most productive journals, x indicates number of journals in the same 
discipline and y stands for number of journals unrelated discipline (y > x) and a 
and b are two constants. 
1.8 SUBDIVISIONS OF BIBLIOMETRICS 
Operation Research (Linear Programming, Transport problems) 
Statistics (Multivariable techniques, trends, correlation) 
Bibliometrics Laws (Laws of Zipf, Lotka and Bradford) 
Citation Analysis (Networks, Science policy) 
Circulation theory (Models). 
Information Theory. 
Theoretical aspects of information and retrieval. 
1.9 BIBLIOMETRICS: ITS APPLICATIONS 
The techniques of bibliometrics have extensive applications equally in 
sociological studies of science, information management. Librarianship, history 
of science including science policy, study of science and scientists and also in 
different branches of social sciences. 
Some of the areas where bibliometrics techniques can be used are: 
1. to identify research trends and growth of knowledge. 
2. to estimate comprehensiveness of secondary periodicals. 
3. to identify users of different subjects. 
(5) 
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4. to identify authorship and its trends in documents on various subjects. 
5. to measure the usefulness of adhoc and retrospective SDI services. 
6. to forecast, present and future publishing trends. 
7. to develop experimental models correlating existing ones. 
8. to identify core periodicals in different disciplines. 
9. to formulate an accurate need-based acquisition policy within the limited 
budgetary provision. 
10. to adopt an accurate weeding and stacking policy. 
11. to initiate effective multi-level network system. 
12. to study obsolescence and dispersion of scientific literature (clustering 
and coupling of scientific papers). 
13. to predict productivity of publishers, individual authors, organizations, 
country or that of an entire discipline. 
14. to design automatic language processing for auto-indexing, and 
abstracting and auto classification; and 
15. to develop norms for standardization. 
1.10 LIMITATIONS IN APPLICATIONS 
Though most of the studies tend to support the Bradford distribution 
some other researcher could not get the satisfactory results. Gross found that 
the scatter of research papers among physics journals deviated from that 
predicted by Bradford's Law. Out of 50 Bibliographies studies by Chonez, only 
six followed the law. Therefore, he calls the law pseudo scientific. 
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Lotka's Law 
In the case of Lotka's Law it was found to fit in most cases. However the 
value of indenting was found to vary for different groups of scientists. 
Another problem with Lotka's law is that it totally ignores the potential 
authors who have not produced any publication so for. 
1.11 CONCLUSION 
Bibiliometric studies have enabled to develop a body of theoretical 
knowledge and a group of techniques and have facilitated its application for the 
further growth of knowledge based on bibliographical data. Bibliometrics has 
contributed greatly to the development of library and information science. The 
subject is still at a developmental stage and there is a great possibility of 
Bibliometric studies in various aspects of library and information work. 
Bibliometrics has emerged as the most active field of Library and Information 
Science during the past few decades. It is estimated that literature on this topic 
occupies more than 25% of the total contribution in library and information 
science. 
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CHAPTER - 2 
HEART - TRANSPLANTATION 
INTRODUCTION 
Heart transplantation is now a routine procedure and an integral part of 
modern cardio thoracic surgery. Heart transplantation is now an established 
therapy for end-stage of the heart disease. 
The first heart transplants were performed in the late 1960s. But it was 
not until the use of anti rejection medicine in the 1980s that the procedure 
become an accepted operation. Today, heart transplantation provides hope for 
a select group of patients who would otherwise die of heart failure. Established 
in 1982, the transplant program of St. Luke's Episcopal Hospital and the Taxes 
Heart experienced, successful programes in the world. Its surgeons have 
performed more than 920 transplant procedures. The key to the programe's 
success is an experienced, highly skilled transplant team that includes 
surgeons, cardiologists, nurses, operating room personal, social workers, psy 
chologists dietitions, rehabilitation specialists, and many after professionals. 
The team works to meet every need faced by transplant candidates, including 
emotional, family and financial needs. 
The first human heart transplant was peri'ormed by Christian Bernard in 
December 1967 in cape town During the next decade considerable advances 
were made by Dr. Shumway's group at stanfard University. The first adult 
cardiac transplant in the USA by Shumway in January 1968. During this period, 
cardiac transplantation has evolved from a highly experimental procedure with 
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a poor out come to an accepted, validated form of surgical therapy for terminal 
heart disease with predictably good results in terms of patient survival and 
rehabilitation. This evaluation has originated largely from surgical empiricism 
rather than from fundamental developments in immunology. Much credit is due 
to the group of workers at Stanford University, led by Dr. Norman Shumway, 
who have pioneered several major advances in cardiac transplantation that 
have contributed significantly to the current by successful results. 
The advances include the application of the endmyocardial biopsy 
technique and the use of anti thy mocyte globulin for the treatment of rejection 
in the mid 1970s, and the introduction of cyclosporine for immunosuppression 
in 1980. More gradual refinements donor selection, infection disease 
preservation, resulting in increased survival, reduced morbidity and the 
concomitant reduction of hospital stay and cost. 
2.1 DEFINITION 
Heart Transplantation, also called cardiac transplantation, is the 
replacement of a patient's diseased or injured heart with a healthy donor heart. 
2.2 HISTORY 
There are several mentions of heart transplantation in ancient Chinese 
mythology and biblical reference, but not until the pioneering work of Alexis 
Carrel at the beginning of the 20**^  century did surgeons have the ability to 
transplant organs such as the heart. In a number of imaginative experiments 
Carrel demonstrated that a heart could be transplanted and resume functioning 
in the new host. 
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With the advent of techniques for successful cardiac surgery in the 
1950's major attention was finally directed to the problem of transplantation of 
the heart in the chest in the normal or orthotopic position. The current most 
commonly used surgical technique for heart transplantation originated with the 
work of Lower and Shumway in 1959. A number of important questions about 
transplants, including protocols for immunosuppression correlation of surface 
electrocardiogram with allograft rejection and several of these changes with 
augmented immunosppression, were subjects of early laboratory study. 
Despite of this laboratory work, many were surprised when the first human 
heart transplant was performed by Christian Barnard in Cape town, South 
Africa in December 1967. 
This transplant initiated a great amount of interest at other centers 
around the world, with 170 transplants by 65 surgical teams between 
December 1967 and March 1971. The One year survival was only 15 percent 
and because of this enthusiasm for heart transplantation rapidly wanted by the 
end of 1971. 
Only at Stanford University and the Medical College of Virginia did 
surgical teams continue with programs in heart translation. Working virtually 
alone through the decade of the 1970's these investigator refined recipient 
selection criterial, saw the developments of Tran venous endomyocardial 
biopsy for diagnosing rejection developed on effective treatment of acute 
rejection and defined many of the late post transplant complications and 
management principles. 
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2.3 NEED AND PURPOSE 
The need for a heart transplant can be traced to one of many heart 
problems, each of which causes damage to the heart muscle. The two most 
common heart problems are coronary artery disease (the build up of plague in 
the arteries of the heart) and idiopathic cardimyopathy (disease of the heart 
muscle without a known cause). 
As the heart problem gets worse the heart grows weaker and is less 
able to pump oxygen rich blood to the rest of body. Because the heart must 
work harder to pump blood through the body, it tries to make up for this extra 
wo rk by becoming enlarged (hypertrophied). In time, the heart works so hard to 
pump blood that it may simply "wear out". It is unable to meet even the smallest 
pumping demands. Medicines, mechanical devices to assist the heart, and 
other therapies can sometimes help and even improve a patient's condition. 
But when those treatments fail, transplantation becomes the only option. 
The purpose of heart transplantation is to extend and improve the life of 
a person who would otherwise die from heart failure. 
2.4 PRECAUTIONS 
Because healthy donor hearts are in short supply, strict rules dictate who 
should or should not get a heart transplant. Patients who have conditions that 
might cause the new heart to fail should not have a heart transplant. Similarly, 
patients who may be too sick to survive the surgery or the side effects of the 
drugs they must take to keep their new heart working would not be good 
transplant candidates. 
(g) 
3iear{ — [Jranspfan/a/ion 
Patients who have any of the following conditions may not be eligible for heart 
transplantation: 
• active infection 
• pulmonary hypertension 
• chronic lung disease with loss of more than 40% of lung function 
• untreatable liver or kidney disease 
• diabetes that has caused serious damage to vital organs 
• disease of the blood vessels in the brain, such as a stroke 
• serious disease of the arteries 
• mental illness or any condition that would make a patient unable to take 
the necessary medicines on schedule 
<* continuing alcohol or drug abuse 
2.5 DESCRIPTION 
Patients with end-stage heart disease that threatens their life even after 
medical treatment may be considered for heart transplantation. Potential 
candidates must have a complete medical examination before they can be put 
on the transplant waiting list. Many types of tests are done, including blood 
tests, X rays, and tests of heart, lung, and other organ function. The results of 
these tests indicate to doctors how serious the heart disease is and whether or 
not a patient is healthy enough to survive the transplant surgery. 
2.6 ORGAN WAITING LIST 
A person approved for heart transplantation is placed on the heart 
transplant waiting list of a heart transplant center. All patients on a waiting list 
are registered with the United Network for Organ Sharing (UNOS). UNOS has 
(2S) 
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organ transplant specialists who run a national connputer network that connects 
all the transplant centers and organ-donation organizations. 
When a donor heart becomes available, information about it is entered 
into the UNOS computer and compared to information from patients on the 
waiting list. The computer program produces a list of patients ranked according 
to blood type, size of the heart, and how urgently they need a heart. Because 
the heart must be transplanted as quickly as possible, the list of local patients is 
checked first for a good match. After that, a regional list, and then a national 
list, are checked. The patient's transplant team of heart and transplant 
specialists makes the final decision as to whether a donor heart is suitable for 
the patient. 
2.7 ORGANIZATION OF A TRANSPLANT PROGRAMME 
The development of an effective cardiac Transplant program requires 
careful organization and cooperation from both clinical and non-clinical 
personnel. Some but not all states requires a certificate of need to initiate a 
new program of heart transplantation. The national organ transplantation Act of 
1984 established certain minimum criteria for transplant program to enroll in the 
nation wide computerized matching system. To encourage excellent patient 
care and to discourage transplantation in centers with sub optional results, the 
act established the United Network for Organ sharing (UNOS) with membership 
limited to those centers that perform a minimum of 12 transplant procedures 
per year and that obtain a one year survival rate of at least 20 percent. 
In most cases, your personal doctor will make the first inquiry about a 
transplant. Doctors who contact a transplant team will talk about your medical 
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history, current conditions, physical abilities, test results and other important 
information. Your doctor will be asked to send your records to the transplant 
team so they can carefully review your medical history, You must then have a 
complete evaluation to find out how server your condition is and whether other 
therapies may help you. 
*:* Recipient selection 
With improved outcomes in both quality of life and percentage of 
patients surviving, cardiac transplantation has become accepted therapy for 
many patients with end-stage of heart disease. A fairly rigid selection process is 
required in order to obtain excellent results in individual patients. The number 
of potential recipients rises exponentially with an extension of the upper age. All 
conventional medical or surgical therapies should be used before consideration 
of transplantation. 
<* Upper age limit 
One of the most controversial aspects of patient selection is the upper 
age limit for cardiac transplantation. The initial Stanford University criteria 
considered an upper age limit of 50 years. This was modified to include 
patients older than 55 and then up to age 60 during the era of improving results 
because of cyclosporine therapy in the early 1980's. 
The transplant candidates who have the best results are younger than 
60 years old and have no serious medical problems other than those with their 
heart. Patients older than 60 are considered for transplant on an individual 
basis. 
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*> Clinical Considerations 
Ultimately, the selection of a candidate for heart transplantation results 
fronn a clinical assessment that a patient free of established contraindications 
(Advanced age (770 years) Irreversible heptic renal or pulmonary dysfunction, 
servers peripheral vascular or care brovascular disease' Insulin-requiring 
diabetes mellitus with end-organ damage, active infection, Recent cancer with 
uncertain status, Psychiatric illness, poor medical compliance, systemic 
disease that would significantly limit survival or rehabilitation, pulmonary 
hypertension with pulmonary vascular resistance etc.) suffers expert 
management. 
*> Coexisting Disease 
Patients with involvement of other organ that precluded selection in the 
past, but that now respond to transplantation, may be considered candidates 
for dual organ transplantation. Dual organ candidacy does not change a 
patients status or position the waiting list but when patients become eligible for 
a heart or liver based on standard criteria, the second required organ may be 
allocated from the same donor. The ethical dilemma of improving one life 
instead of two remains unresolved. 
*> Cost and Insurance Coverage 
The total cost for heart transplantation varies, depending on where It is 
performed, whether transportation and lodging are needed, and on whether 
there are any complications. The costs for the surgery and first year of care are 
estimated to be about $250,000. The medical tests and medications after the 
first year cost about $21,000 per year. 
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Insurance coverage for heart transplantation.varies depending on the 
policy. Most commercial insurance companies pay a certain percentage of 
heart transplant costs. Medicare pays for heart transplants if the surgery is 
performed at Medicare-approved centers. Medicaid pays for heart transplants 
in 33 states and in the District of Colombia. 
• Waiting for a New Heart 
Once you are accepted into a transplant program, the wait for a new 
heart begins. A number of factors determine your place on the waiting list for a 
donor heart. These factors include blood type, size match between you and the 
donor, your medical condition, and how long you are able to wait for a new 
heart. The order of the waiting list can change. Sometimes patients improve 
enough from other treatments to be taken off the list. Other patients may 
become sicker, so they move higher on the list. The use of left ventricular assist 
devices has reduced the urgency of some patients wait for a donor heart. 
These devices are connected to the heart during an operation. They help the 
heart to pump until a healthy heart can be transplanted. Some of these devises 
can keep patients alive for many moths, while greatly improving their quality of 
life and overall health. In some cases, just raising your heart can improve its 
condition enough to keep you from heeding a transplant. 
*> The Law of Supply and Demand 
Many patients find that waiting for a donor heart is the hardest part of 
the transplantation process. Nobody can tell you when the call will come or how 
long the wail will be. Sadly, this part of the process falls outside of human 
control. 
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The demands for donor hearts is greater than the supply. At any given 
time, about 4,000 patients are on the national patient waiting list for a heart 
transplant, but only about 2,300 donor hearts become available for 
transplantation each year. In the United States, the United Netv\/ork for Organ 
Sharing (UNOS) determines priority for a heart transplant by grouping patients 
by the severity of their heart condition. This grouping lets those who need a 
transplant must be considered first. The grouping are as follows: 
Status 1A - includes very ill patients who need constant inotropic 
medicines or mechanical assistance (left ventricular assist devices); these 
patients are expected to live less than one month without a transplant. 
Status 1B - includes medically stable patients who need constant 
inotropic medicines or mechanical assistance (left ventricular assist devices); 
these patients are expected to live more than one month without a transplant. 
Status 2 - All patients who do not meet the above standards. 
Donor hearts usually come from people who have died of injuries that 
have spared the heart. Matching these donors with transplant candidates can 
be difficult. First, trauma patients must be quickly taken to hospitals and 
identified as donors. The hospital must have approval to remove the donor 
heart. Medical and laboratory tests are needed to find out the condition of the 
donor heart and what the donor's blood type is. When a donor and a candidate 
are in different parts of the country, it becomes a race against time. A donor 
heart cannot safely be outside of the body for more than four hours. In the 
United States, 141 UNOS-approved heart transplant programs work together to 
make sure that every donor heart that can be used is used. 
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• The Wait Ends 
You must wear a beeper at all times to make sure that you know right 
away if a donor heart is found. Once you receive the long-awaited news, time is 
very important. You must have a final evaluation and laboratory work-up at the 
hospital before going into the operating room. If there are no complications, a 
transplant operation takes about 3 hours to complete. 
After transplant, you will spend 1 or 2 days in the recovery room, 2 or 3 
days in the intensive care unit, and about 7 days in a private room in the 
transplant unit. During this time, you will undergo constant monitoring and 
testing, including regular heart biopsy procedures. A heart biopsy involves 
removing small pieces of tissue from your new heart to see if your body is 
rejecting the organ. For a 3-month period after leaving the hospital, you must 
go back to the hospital for regular checkups. These checkups let members of 
the transplant team watch you closely for signs of rejection or other 
complications. 
Although most transplants are successful, some do not turn out as 
hoped. In some cases, the donated heart simply does not work. This is called 
"graft failure," and it becomes obvious in the operating room or shortly after 
surgery. Another major cause of failure is "tissue rejection." The body's immune 
system knows that the donated heart is foreign tissue and tries to destroy it, as 
if it were a virus or some other disease-causing agent. There is no other way to 
check for signs of rejection, except through routine biopsy of heart tissue. 
Transplant recipients have an increased risk of infection, especially during the 
first 6 months after transplantation, because of the medicines they must take to 
® 
Jfear/ — Uranspfaniaiion 
prevent rejection. These medicines, called immunosuppressants, make it 
harder for the body to fight off disease. Sometimes these medicines can let an 
infection turn into a serious medical problem long after surgery. 
<• Return to Normal Living 
With the proper care and by following the advice of your doctor, patients 
who are fortunate enough to receive a donor heart can look fon/vard to a full 
and productive life. 
2.8 SURGICAL TECHNIQUES 
The cardiac donor operation hoes not require cardiopulmonary bypass 
and can be performed easily in any standard operating room. After systemic 
hyalinization and cold cardiologic arrest, the heart is excised and placed in cold 
saline or cardiologic solution at 4°C for storage and transportation is a standard 
insulated container. 
Orthotopec cardiac transplantation is the technique of choice in most 
transplant centers. One additional modification introduced is that the right 
astronomy incision is curved away from the donor sino-atrial node to avoid 
Injury to that structure allowing for normal sinus rhythm in the transplanted 
heart. After the initiation of cardiopulmonary bypass, the recipient's own heart is 
excised at mid-atrial level leaving cuffs of right and left atrium with intervening 
intertribal septum. The aorta and pulmonary artery are divided at valvar levels. 
After preparation of the donor heart, the anastomoses are performed in the 
following order: left atrium, right atrium, aorta and pulmonary artery. 
Heterotopy cardiac transplantation (piggy-back operation) is performed 
less frequently and probably should be reserved for circumstances in which the 
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donor is of significantly smaller size than the recipient and where the donor 
heart could not be reasonably expected to maintain the recipient circulation. 
2.9 HEART SURGERY OVERVIEW 
Thousands of heart surgeries are performed every day in the United 
States. In fact, in 2000 alone, surgeons perfomied more than 600,000 coronary 
bypass or valve repair and replacement surgeries. And even though there is a 
shortage of donor organs, about 2,000 people had heart transplants. 
Years ago, many doctors thought that heart surgery was a dream. 
Surgeons during World War II had learned how to operate on the heart, but 
they could not carry out what they had learned because it was hard to operate 
on a beating, moving heart. Also, the heart could not be stopped for more than 
a few minutes without causing brain damage. 
Two major advances in medicine made heart surgery possible: 
• The heart-lung machine, which takes over the work of the heart. 
• Body cooling techniques, which allow more time for surgery without 
causing brain damage. 
What is a heart-lung machine? 
The heart-lung machine is also called a cardiopulmonary bypass 
machine. It takes over for the heart by replacing the heart's pumping action and 
by adding oxygen to the blood. This means that the heart will be still for the 
operation, which is necessary when the heart has to be opened (open heart 
surgery). Because the heart-lung machine takes over the work of the heart, 
surgeons can operate on a heart that is not moving or full of blood. 
® 
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When you are.connected to the heart-lung machine, it does the same 
job that your heart and lungs would do. The heart-lung machine carries blood 
from the upper-right chamber of the heart (the right atrium) to a special 
reservoir called an oxygenator. Inside the oxygenator, oxygen bubbles up 
through the blood and enters the red blood cells. This causes the blood to turn 
from dark (oxygen-poor) to bright red (oxygen-rich). Then, a filter removes the 
air bubbles from the oxygen-rich blood, and the blood travels through a plastic 
tube to the body's main blood conduit (the aorta). From the aorta, the blood 
moves throughout the rest of the body. 
The heart-lung machine can take over the work of the heart and lungs 
for hours. Trained technicians called perfusion technologists (blood flow 
specialists) make sure that the heart-lung machine does its job properly during 
the surgery. Even so, surgeons still try to limit the time that patients must spend 
hooked up to the machine. 
What are cooling techniques? 
Cooling techniques let surgeons stop the heart for long periods without 
damaging the heart tissue. Cool temperatures avoid damage to the heart tissue 
by reducing the heart's need for oxygen. 
The heart may be cooled in 2 ways: 
• Blood is cooled as it passes through the heart-lung machine. In turn, this 
cooled blood lowers body temperature when it reaches all of the body 
parts. 
• Cold salt-water (saline) is poured over the heart. 
® 
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After cooling, the heart slows and stops. Injecting a special potassium 
solution into the heart can speed up this process and stop the heart completely. 
The heart is then usually safe from tissue injury for 2 to 4 hours. 
Who is in the operating room during surgery? 
During heart surgery, a highly trained group works as a team. Here is a 
list of people who will be in the operating room during surgery. 
• The cardiovascular surgeon, who heads up the surgery team and 
performs the key parts of the surgery. 
• The assisting surgeons, who follow the direction of the cardiovascular 
surgeon. 
• The cardiovascular anesthesiologist, who gives you the medicines that 
make you sleep during the surgery (called anesthesia). The 
anesthesiologist makes sure that you get the right amount of medicines 
throughout the surgery and monitors the ventilator, which breathes for 
you during surgery. 
• The perfusion technologist, who runs the heart-lung machine. 
<• The cardiovascular nurses, who are specially trained to assist in heart 
surgery. 
What kinds of heart and blood vessel surgeries are there? 
Many different kinds of surgery are now performed on the heart or blood 
vessels. 
36 
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2.10 CORONARY ARTERY BYPASS 
This is the most common kind of heart surgery called coronary artery 
bypass graft surgery (CABG), coronary artery bypass (CAB), coronary bypass 
or just bypass surgery. 
The words single bypass, double bypass, triple bypass, or quadruple 
bypass, it refers to the number of arteries that are bypassed. The number of 
bypasses does not necessarily indicate how severe the heart condition is. 
2.10.1 CORONARY ARTERY BYPASS SURGERY 
Bypass surgery is the most common type of heart surgery. More than 
300,000 people have successful bypass surgery in the United States each 
year. 
Arteries can become clogged over time by the buildup of fatty plaque. 
Bypass surgery improves the blood flow to the heart with a new route, or 
"bypass," around a section of clogged or diseased artery. 
The surgery involves sewing a section of vein from the leg or artery from 
the chest or another part of the body to bypass a part of the diseased coronary 
artery. This creates a new route for blood to flow, so that the heart muscle will 
get the oxygen-rich blood it needs to work properly. 
During bypass surgery, the breastbone (sternum) is divided, the heart is 
stopped, and blood is sent through a heart-lung machine. Unlike other forms of 
heart surgery, the chambers of the heart are not opened during the operation. 
What to Expect 
The operation will usually be scheduled at a time that is best for you and 
your surgeon, except in urgent cases. As the date of your surgery gets closer, 
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be sure to tell your surgeon and cardiologist about any changes in your health. 
If you have a cold or the flu, this can lead to infections that may affect your 
recovery. Be aware of fever, chills, coughing, or a runny nose. Tell the doctor if 
you have any of these symptoms. 
Also, remind your cardiologist and surgeon about all of the medicines 
you are taking, especially any over-the-counter medicines like aspirin or those 
that might contain aspirin. You should make a list of the medicines and bring it 
with you to the hospital. 
It is always best to get complete instructions from your cardiologist and 
surgeon about the procedure, but here are some basics you can expect as a 
bypass patient. 
Before the Hospital Stay 
Most patients are admitted to the hospital the day before surgery or, in 
some cases, on the morning of surgery. 
The night before surgery, you will be asked to bathe to reduce the 
amount of germs on your skin. After you are admitted to the hospital, the area 
to be operated on will be washed, scrubbed with antiseptic, and, if needed, 
shaved. 
A medicine (anesthetic) will make you sleep during the operation. This is 
called "anesthesia." Because anesthesia is safest on an empty stomach, you 
will be asked not to eat or drink after midnight the night before surgery. If you 
do eat or drink anything after midnight, it is important that you tell your 
anesthesiologist and surgeon. 
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If you smoke, your doctor will want you to stop at least 2 weeks before 
your surgery. Smoking before surgery can lead to problems with blood clotting 
and breathing. 
Life After Bypass 
After bypass surgery, you should limit the fat and cholesterol in your diet. 
Your doctor may recommend walking or swimming to get your strength back. 
Your doctor may also recommend that you join a cardiac rehabilitation 
program. These programs can help you make lifestyle changes like starting a 
new diet and exercise program, quitting smoking, and learning to deal with 
stress. 
If you have an office job, you can usually go back to work in 4 to 6 
weeks. Those who have more physically demanding jobs may need to wait 
longer. In some extreme cases, you may need to find a job that is not as 
physically demanding. Twenty to 30% of bypass patients will need a second 
procedure within 10 years. 
Valve repair or replacement 
Blood is pumped through your heart in only one direction. Heart valves 
play key roles in this one-way blood flow, opening and closing with each 
heartbeat. Pressure changes behind and in front of the valves allow them to 
open their flap-like "doors" (called cusps or leaflets) at just the right time, then 
close them tightly to prevent a backflow of blood. 
(33) 
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Two of the most common kinds of valve problems that require 
surgery are 
• Stenosis, which means the leaflets do not open wide enough and only a 
small amount of blood can flow through the valve. Stenosis occurs when 
the leaflets thicken, stiffen, or fuse together. Surgery is needed to either 
open the valve that is there or replace it with a new one. 
• Regurgitation, which is also called insufficiency or incompetence, 
means that the valve does not close properly and blood leaks backward 
instead of moving in the proper forward direction. Surgery is needed to 
either tighten or replace the valve. 
Surgical repair of a valve involves the surgeon rebuilding the valve so 
that it will work properly. Valve replacement means that the valve is replaced 
with a biological valve (made of animal or human tissue) or a mechanical valve 
(made from materials such as plastic, carbon, or metal). 
*:• Valve Disease 
Every time your heart beats, blood flows into, through, and out of your 
heart. In fact, your heart moves about 100 gallons (379 liters) of blood through 
your body every hour. 
There are 4 valves in the heart: 
<• Tricuspid valve 
<• Pulmonary valve 
<• Mitral valve 
• Aortic valve 
® 
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Blood without oxygen returns from the body and flows into the heart's 
upper-right chamber (the right atrium). From there, it is forced through the 
tricuspid valve into the lower-right chamber (the right ventricle). The right 
ventricle pumps the blood through the pulmonary valve and into the lungs. 
While in the lungs, the blood picks up oxygen. As the right ventricle is preparing 
to push blood through the pulmonary valve, the tricuspid valve closes to stop 
blood from flowing back into the right atrium. 
Oxygen-rich blood returning from the lungs flows into the upper-left 
chamber (the left atrium). This blood is forced through the mitral valve into the 
lower-left chamber (the left ventricle)—^with the mitral valve sealing off to stop 
the backflow of blood. At the same time that the right ventricle is pumping the 
blood without oxygen into the lungs, the left ventricle is pushing the blood with 
oxygen through the aortic valve and on to all of the body's organs. 
Two types of problems can disrupt blood flow though the valves: 
regurgitation or stenosis. 
<* Transmyocardial Laser Revascularization (TMLR or TiVIR) 
Like every other organ or tissue in your body, the heart muscle needs 
oxygen-rich blood to survive. The heart gets this blood from the coronary 
arteries. But in patients with coronary artery disease (CAD), the coronary 
arteries are clogged and diseased and can no longer deliver enough blood to 
the heart. The heart's lack of oxygen-rich blood is called ischemia. 
Not getting enough oxygen to the heart muscle increases the risk of 
heart attack and may cause a painful condition called angina. Patients often 
say that angina feels like a squeezing, suffocating, or burning feeling In their 
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chest. The pain usually occurs when the heart has an extra demand for blood, 
such as during exercise, after eating, or at times of stress. 
Most of the time, the best treatment for angina is coronary artery bypass 
surgery. But for some patients with very serious heart disease or other health 
problems, bypass surgery may be too dangerous. Also, some patients may 
have had many coronary artery bypass operations and may not be able to have 
more bypass operations. 
For patients who cannot have bypass surgery, there is a procedure 
called transmyocardial laser revascularization, also called TMLR or TMR. 
TMLR cannot cure CAD, but it may reduce the pain of angina. 
What is Transmyocardial Laser Revascularization (TMLR)? 
TMLR is a type of surgery that uses a laser to make tiny channels 
through the heart muscle and into the lower-left chamber of the heart (the left 
ventricle). The left ventricle is the heart's main pumping chamber. 
After TMLR, when oxygen-rich blood enters the left ventricle, some of that 
blood can flow through the tiny channels and carry much-needed oxygen to the 
starving heart muscle. 
No one really knows why TMLR helps reduce the pain of angina. Some 
doctors think that TLMR helps the growth of tiny new blood vessels in the heart 
muscle wall. This process is called angiogenesis. These new blood vessels 
bring more blood to the heart muscle, making it healthier. Others think that the 
TMLR laser destroys some of the pain-causing nerves in the heart muscle. Stilt 
others think that patients feel a placebo effect. This means that patients feel 
better because they got treatment, not because the treatment really worked. 
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TMLR is surgery, but it can be done while the heart is still beating and 
full of blood. That means that a heart-lung machine is not needed. Also, 
surgeons do not cut open the chambers of the heart, so TMLR is not open 
heart surgery. 
2.11 AFTERCARE 
Immediately following surgery, patients are monitored closely in the 
intensive care unit (ICU) of the hospital for 24-72 hours. Most patients need to 
receive oxygen for four to 24 hours following surgery. Blood pressure, heart 
function, and other organ functions are carefully monitored during this time. 
Heart transplant patients start taking immunosuppressive drugs before 
or during surgery to prevent immune rejection of the heart. High doses of 
immunosuppressive drugs are given at this time, because rejection is most 
likely to happen within the first few months after the surgery. A few months after 
surgery, lower doses of immunosuppressive drugs usually are given and must 
be taken for the rest of the patient's life. 
For six to eight weeks after the transplant surgery, patients usually come 
back to the transplant center twice a week for physical examinations and 
medical tests. These tests check for any signs of infection, rejection of the new 
heart, or other complications. 
In addition to physical examination, the following tests may be done during 
these visits: 
• laboratory tests to check for infection 
• chest x ray to check for early signs of lung infection 
• electrocardiogram (ECG) to check heart function 
(45) 
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• echocardiogram to check the function of the ventricles in the heart 
•:• blood tests to check liver and kidney function 
•:• complete blood counts (CBC) to check the numbers of blood cells 
<• taking of a small tissue sample from the donor heart (endomyocardial 
biopsy) to check for signs of rejection. 
During the physical examination, the blood pressure is checked and the 
heart sounds are listened to with a stethoscope to determine if the heart is 
beating properly and pumping enough blood. Kidney and liver function are 
checked because these organs may lose function if the heart is being rejected. 
An endomyocardial biopsy is the removal of a small sample of the heart 
muscle. This is done with a very small instrument that is inserted through an 
artery or vein and into the heart. The heart muscle tissue is examined under a 
microscope for signs that the heart is being rejected. Endomyocardial biopsy is 
usually done weekly for the first four to eight weeks after transplant surgery and 
then at longer intervals after that. 
2.12 IMMUNOSUPPRESSION 
Immuunosuppressive method have evolved over the last twenty years 
based on the empirical application by surgeons of different drugs and drug 
combinations. 
The level of immunosuppression needs to be greates early after 
transplantation when the propensity to rejection is greatest, but, although the 
likelihood of rejection decreases with times, patients need to be on 
maintenance immunosuppressive therapy for life. 
® 
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2.13 REJECTION 
Cardiac rejection associated with cyciosporing, however, cannot be 
detected reliably, clinically, and historical examination of endmyocardial biopsy 
specimens remains the 'gold standard' for the diagnosis of cardiac rejection. 
Much effort has been expended in searching for a reliable non-invasive 
method for the diagnosis of cardiac rejection, but nuclear medical techniques, 
echocardiography , cyto-immuunological monitoring, nuclear magnetic resource 
and more sophisticated electrocardiography analysis have not yet proven to be 
of sufficient value to allow the discontinuation of cardiac biopsy. 
2.14 MANAGEMENT OF INFECTION 
Infection and rejection remain the two major causes of death following 
cardiac transplantation. The majority of deaths are likely to be due to infection 
rather than rejection; with 'under' immunosuppression, the reverse is true. 
Pre-operative prophylactice antibiotics are given until the intracenous 
lines and catheters are removed. In the presence of infection, 'blind' antibiotic 
therapy is contra-indicated unless life-threatening undiafnosed infection exists. 
Great efforts are pt into the rapid investigation of any potential infection 
including the early use of invasive techniques, such as transthoracic needle 
biopsy and fibre-optic bronchoscopy for the diagnosis of pulmonary infection. 
2.15 RISKS 
The most common and dangerous complications of heart transplant 
surgery are organ rejection and infection. Immunosuppressive drugs are given 
to prevent rejection of the heart. Most heart transplant patients have a rejection 
episode soon after transplantation, but doctors usually diagnose it immediately 
Dieari — Uransplanlalion 
when it will respond readily to treatment. Rejection is treated with combinations 
of immunosuppressive drugs given in higher doses than maintenance 
immunosuppression. Most of these rejection situations are successfully treated. 
Infection can result from the surgery, but most infections are a side effect of the 
immunosuppressive drugs. Immunosuppressive drugs keep the immune 
system from attacking the foreign cells of the donor heart. However, the 
suppressed immune cells are also unable to adequately fight bacteria, viruses, 
and other microorganisms. Microorganisms that normally do not affect persons 
with healthy immune systems can cause dangerous infections in transplant 
patients taking immunosuppressive drugs. 
Patients are given antibiotics during surgery to prevent bacterial 
infection. Patients may also be given an antiviral drug to prevent virus 
infections. Patients who develop infections may need to have their 
immunosuppressive drugs changed or the dose adjusted. Infections are treated 
with antibiotics or other drugs, depending on the type of infection. 
Other complications that can happen immediately after surgery 
are: 
• bleeding 
• pressure on the heart caused by fluid in the space surrounding the heart 
(pericardial tamponade) 
•:• irregular heart beats 
*> reduced cardiac output 
•:• increased amount of blood in the circulatory system 
• decreased amount of blood in the circulatory system 
(5) 
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About half of all heart transplant patients develop coronary artery disease 1-5 
years after the transplant. The coronary arteries supply blood to the heart. 
Patients with this problem develop chest pains called angina. Other names for 
this complication are coronary allograft vascular disease and chronic rejection. 
2.16 OUTCOMES 
Heart transplantation is an appropriate treatment for many patients with 
end-stage heart failure. The outcomes of heart transplantation depend on the 
patient's age, health, and other factors. About 73% of heart transplant patients 
are alive four years after surgery. 
After transplant, most patients regain normal heart function, meaning the 
heart pumps a normal amount of blood. A transplanted heart usually beats 
slightly faster than normal because the heart nerves are cut during surgery. 
The new heart also does not increase its rate as quickly during exercise. Even 
so, most patients feel much better and their capacity for exercise is dramatically 
improved from before they received the new heart. About 85% of patients 
return to work and other daily activities. Many are able to participate in sports. 
National Transplant Waiting List By Organ Type (June 2000)Organ Needed 
Number Waiting Kidney48, 349Liver15, 987Heart4, 139Lung3, 695Kidney-
Pancreas2, 437Pancreas942Heart-Lung212lntestine137 
2.17 THE "ARTIFICIAL" HEART 
It is nine o'clock on a Saturday morning when the chopper lands on the 
helistop atop the Texas Heart Institute at St. Luke's Episcopal Hospital — The 
Denton A. Cooley Building. The patient is 37-year-old Michael Kavanaugh, and 
he has had a major heart attack. By mid afternoon, tests have determined that 
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the heart attack has completely destroyed Mike's heart. At the most, he has 
only a few days to live. His only hope now is a new heart. A surgical team 
begins the critical measurements and evaluations. Surgery is scheduled within 
36 hours. As the procedure gets undenvay, Dr. O. H. Frazier reaches for an 
AbioCor™ Replacement Heart. The year is 2005. 
This scenario is far from fantasy. In fact, researchers and doctors at the 
Texas Heart Institute (THI) have been working for more than 30 years to have 
readily at hand an artificial heart such as the AbioCor, as well as a variety of 
other heart assist or replacement devices. The devices could indeed save 
thousands of lives each year. 
"Currently, about 60,000 Americans die each year from heart damage 
caused by a sudden, massive heart attack. Increasingly, we are seeing this 
happen among younger and younger people — men in their 30s, women in 
their 40s. This is just one patient population that could benefit from the artificial 
heart technology currently being evaluated," said O.H. Frazier, M.D., Chief of 
Cardiopulmonary Transplantation and Director of Surgical Research at THI and 
Chief of Transplant Service at St. Luke's. 
ABIOMED, Inc., the Danvers, Massachusetts, firm that designed and 
manufactured the AbioCor in conjunction with Dr. Frazier's research team at 
THI, projects that at least 100,000 people could benefit from the AbioCor each 
year. Company officials also project that with full-scale manufacturing, the cost 
of the device could drop to between $30,000 and $60,000, far below the 
estimated cost of a heart transplant. 
® 
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"The impetus for this research in the first place is that there are simply 
not enough donor hearts for everyone who needs one. Half the people who 
even get on the waiting list die before a heart becomes available," said Dr. 
Frazier. With nearly 900 heart transplants to his record, Dr. Frazier has 
performed more than any other surgeon in the world. Of course, one thing I've 
always regretted is that in order to get a donor heart, you have to rely on the 
misfortune of others," he said. "Most people don't realize that transplants 
require considerable medical resources, and the patients must be followed 
carefully for the duration of their lives after transplantation. The cost just keeps 
going up and up." The AbioCor clinical study now undenway is the first step of 
many toward eventually eliminating the need for donor hearts. An unfortunate 
but necessary mandate of the Food and Drug Administration (FDA) protocol for 
studying this device in humans is that patients eligible for the study have a high 
probability of dying within 30 days. As this publication goes to press, five men 
have successfully received the AbioCor, and ABIOMED has FDA approval to 
move fonward with additional patients in the study. Despite the fact that patients 
who receive the AbioCor have considerable and varying complications from 
being near death, the artificial heart has continued to work flawlessly. 
So How Does it Work? 
"It's magic," said Dr. Frazier. 
To understand the magic, it may help to imagine holding a water balloon 
with two hands. As you squeeze with one hand, the water in the balloon moves 
toward the open hand. 
(£) 
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ARTIFICIAL HEART 
Diagram No. 3 
® 
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At the core of this artificial heart is a tiny motor enclosed in a titanium 
shell. The shell has a "window" on each side of the heart. This entire part of the 
heart is encapsulated in a polyurethane sac of hydraulic fluid. As the motor 
spins in one direction, creating centrifugal force, the "windows" alternately open 
and close, pushing the sac in one direction or another, thereby creating the 
"pulse" which moves blood through the right and left ventricles of the heart. The 
"beat" of this heart is essentially the alternate opening and closing of the 
windows, which can be regulated to a certain speed or operated on a self-
monitoring computer program to regulate blood flow. 
Unlike the natural heart, which fills the ventricles of the heart at 
approximately the same time with one heartbeat, the AbioCor fills the plastic 
ventricles alternately with two beats, yet accomplishes the same function. 
Whereas a healthy human heart beats about 100,000 times a day, the AbioCor 
does double duty. 
The AbioCor has no wires or tubes exiting from the patient's chest. An 
internal battery and controller are implanted with the pump. An external battery 
powers the pump by passing electricity painlessly through the skin. An 
implanted battery can also supply power by itself for about 30 minutes. 
A fascinating part of the pump's design is an internal balancing system in 
which sensors in the heart monitor blood flow in each ventricle and 
automatically adjust the heartbeat to accommodate the changes in blood 
volume that occur with increased motion of the body. This computer technology 
was derived from NASA's space program. 
(53) 
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Dr. Frazier's vision for the artificial heart began as a medical student. 
During his career, he has worked with pioneers — physicians and scientists — 
who have developed and implanted previous versions of artificial hearts. Where 
they proved it could be done, Dr. Frazier was determined to prove that it could 
be done well. 
Over the last 10 years, the innovative developments that evolved into 
the final version of the AbioCor pump were made with the cooperative efforts of 
the THI research team in concert with ABIOMED engineers. ABIOMED 
engineers are already working on the development of a smaller model of the 
AbioCor, so that this technology may be accessible to people with a smaller 
body size, including women and children. It is hoped that the FDA will not 
require a separate study to implement use of a smaller model. 
"The success of this study will be decided not by the outcome of a single 
patient but by a positive outcome in the entire initial study group," said Dr. 
Frazier. "We hope to be able to extend the potential benefits of this technology 
as soon as possible to the tens of thousands of patients dying prematurely of 
heart disease." 
*:* Heart Assist Devices 
One goal of the surgical research conducted at the Texas Heart Institute 
(THI) and St. Luke's Episcopal Hospital is to develop and determine the best 
assist device to use for each individual patient. 
"The devices we've been developing and testing are either ventricular 
assist devices or artificial hearts. They are ail pumps of some type, but they 
(5) 
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each work differently for a specific function," explained Dr. O.H. Frazier, who 
has been instrumental in the development of all the devices pictured below. 
• Ventricular Assist 
The Jarvik 2000® assists the pumping action of the left ventricle, which 
does the majority of the heart's work. Most patients with congestive heart failure 
have lost some function of the left ventricle. THl was the first U.S. center to 
study the Jarvik 2000 pump as a bridge to transplant, meaning the device is 
used to bridge the time until a donor heart can be found for transplant. 
Thoratec Heart Mate ( r ) SNAP-VE Left Ventricular Assist System 
(Thoratec Heart Mate SNAP-VE LVAS) 
The Thoratec Heartmate® SNAP-VE LVAS was developed and tested 
by Thermo Cardiosystems, Inc. and the Texas Heart Institute. In 1991, the 
system was implanted in a patient who was subsequently supported for 505 
days. This patient, who was able to leave the hospital while being supported by 
this device, paved the way for other patients to routinely wait at home for their 
transplants. Because the system is relatively easy to use, patients and their 
families can maintain it outside the hospital setting. Patients can live at home, 
return to work, and resume a more normal lifestyle while awaiting a suitable 
donor heart. Recently, the Food and Drug Administration (FDA) approved the 
HeartMate SNAP-VE LVAS for destination therapy, which means the device 
can be used as permanent support for end-stage heart failure patients who are 
not eligible for heart transplants. ^"""T^VT^dT^^s^ 
\ \cc. No ' 
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• The Pump 
This titanium blood pump consists of a blood chamber, a motor 
chamber, a drive-line, and inflow and outflow conduits. The pump weighs 1150 
grams. Each conduit contains a 25-mm porcine (pig) valve within a woven 
Dacron-fabric graft. A polyurethane diaphragm separates the blood chamber 
and the motor chamber. Textured surfaces within the blood chamber promote 
the development of a cellular lining, which helps prevent blood clots and 
infection. The SNAP-VE LVAS has a maximum stroke volume of 83 milliliters. It 
can be operated at up to 120 beats per minute, resulting in flow rates of up to 
10 liters per minute. 
<* External Equipment 
The SNAP-VE LVAS's external equipment includes a system controller, 
a power base unit, and a 20-foot power cable, as well as batteries and other 
accessories. The system controller continuously monitors and controls the 
implanted motor and shows information regarding alarm conditions. 
The power base unit serves as a battery charger and as an interface 
between the system monitor and the implanted pump. The 20-foot power cable 
allows the system to be operated by AC power. Alternatively, patients can wear 
a portable battery pack around their waist, which permits the system to be 
operated tether-free for up to 8 hours. 
• Thoratec (R) Ventricular Assist Device 
The Thoratec Ventricular Assist Device (VAD) can be used to support 
patients with acute and chronic heart failure. Doctors have gained 
approximately 20 years of experience with this system at numerous medical 
(5) 
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centers around the worid. The Texas Heart Institute began using the Thoratec 
VADin1997. 
The Pump two Thoratec VADs can be used to provide left, right, or 
biventricular support. The blood pump is positioned outside the body 
(extracorporeally) and connected to tubes (called cannulas) inserted into 
the heart. The pump has a rigid plastic case that contains a flexible 
pumping sac. Blood is ejected from the pump when the pumping sac is 
compressed by air from the external control console. Within the inflow 
and outflow conduits, mechanical valves control the direction of blood 
flow. The Thoratec VAD has a stroke volume of 65 milliliters. It can be 
operated at up to 100 beats per minute, resulting in blood flow rates of up 
to 7 liters per minute. 
*> Console 
The Thoratec console has control modules and internal compressors 
that provide pressure and vacuum conditions to the pump. The drive console 
delivers air to the blood pump in a pulse-like fashion, causing blood to be 
ejected into the aorta and/or pulmonary artery. The drive console may be set to 
three different modes of operation: asynchronous mode (pumping occurs at a 
preset rate), synchronous mode (pumping is synchronized with the patient's 
heart rate), or volume mode (pumping is adjusted according to the left 
ventricular filling volume). The console continuously displays the ejection 
pressure, percent ejection time, pump rate, pump flow, and vacuum pressure. 
® 
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Because of the external placement of the pump(s), patient mobility is limited 
with this system. 
• ODEL-7 Abdominal Left Ventricular Assist Device (ALVAD; 
Model-7 Abdominal Left Ventricular Assist Device (ALVAD) 
Between 1975 and 1978, Dr. John Norman and Dr. Denton A. Cooley 
performed a series of implantations of a pneumatic (air-driven) abdominal left 
ventricular assist device (ALVAD). The Model-7 ALVAD was used to support 
post-cardiotomy patients (those whose hearts had failed after heart surgery). 
The device was evaluated in 22 patients at the Texas Heart Institute. 
In February 1978, Drs. Cooley and Norman implanted a Model-7 ALVAD 
in a 21-year-old man whose left ventricle deteriorated after he had undergone 
double heart-valve replacement. The Model-7 ALVAD kept this patient alive 
until he underwent heart transplantation 5 days later. Unfortunately, he died of 
infection after his transplant. 
This clinical trial at THI was the first sponsored by the National Institutes 
of Health to determine the effectiveness of support with a left ventricular assist 
device. These and other trials of the ALVAD demonstrated that patients' hearts 
could in fact be supported with the use of a left ventricular assist device and led 
to the development of more sophisticated pumps. 
• The Pump 
The Model-7 ALVAD is a pneumatic, single-chambered implantable 
blood pump that was placed in the abdomen and connected to the left ventricle 
by a Dacron tube. Blood from the left ventricle flows through the tube and fills a 
polyurethane bladder. When air from the drive-line fills the space between the 
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bladder and the titanium pump housing, the blood is pumped through a disc-
type valve into the aorta and to the body. Polyester fibers coat all of the blood-
contacting surfaces, except the valve discs and the inflow and outflov\/ grafts. 
The fibers promote the development of a cellular lining, which helps prevent 
blood clots and Infection. 
• The Console 
The console provides variable settings of pump chamber pressurization, 
pump chamber filling, and pulse duration. The two modes of operation include 
EKG-triggered pumping (synchronized with the resting and pumping phases of 
the left ventricle) or variable fixed-rate asynchronous pumping. Four fail-safe 
functions are also available in cases of EKG interruption; mechanical or 
electrical failure; loss of external pneumatic power; or loss of AC line power. 
The internal pneumatic and electrical power supplies allow for portable 
operation of the console for up to 50 minutes. 
2.18 HEART TRANSPLANTATION IN CHILDREN 
Although the total number of heart transplant procedures has remained 
relatively constant since 1988, the number of children under going heart 
transplantation is Increasing yearly. Approximately 320 patients under the age 
of 18 years received a heart transplant in 1993, with over 100 being younger 
than 1 year of age. 
Human heart donors subsequently have been initialized, although the 
availability of donors is limited. The longest surviving pediatric heart transplant 
patient is just over 17 years. A one-year survival of about 85 per cent has been 
reported, with excellent early growth and development. There is some evidence 
Jfearl — Uranspfanlalion 
that rejected complications are less frequent in children in whom transplant 
occurs before one month of age. After that time, rejection is clearly common 
and appears to be no less than in adult patients. 
A major drawback to transplantation in children is the need for invasive 
endmyocardial blousy to monitor the function of the transplanted heart. 
Because of these difficulties, Bailey and coworkers have advocated using 
clinical sings together with echocardiography as a means of diagnosing 
rejected episodes. 
2.19 RETRANSPLANTATION 
An important consideration in cardiac transplantation is the question of 
retransplantation. The major indications are (1) the development of graft 
coronary atherosclerosis, (2) treatment of severe acute early rejection, and (3) 
treatment of early acute right heart failure. All of these patient groups are less 
desirable potential recipients than are primary transplant candidates. 
In the largest report, 63 patients undenwent 66 retransplantations out of 
792 total procedures at the Stanford University Medical Center. Seventeen 
patients were treated for early rejection and 37 patients for development of 
coronary artery disease, causes of death were similar to those for other 
transplant recipients, and survival was 55± 8 per cent at one year. 
2.20 ORGANIZATION 
• American Council on Transplantation. P.O. Box 1709, Alexandria, VA 
22313. 1-800-ACT-GIVE. 
® 
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• Health Services and Resources Administration, Division of Organ 
Transplantation. Roonn 11A-22, 5600 Fishers Lane, Rockville, MD 
20857. 
• United Network for Organ Sharing (UNOS). 1100 Boulders Parkway, 
Suite 500, P.O. Box 13770, Richmond, VA 23225-8770. (804) 330-8500. 
http://www.unos.org 
2.21 FUTURE PROSPECTS 
The major challenge in the coming years in the field of cardiac 
transplantation is the control of accelerated arteriosclerosis. It is unlikely that 
improved immunosuppression early after transplantation will result in 
dramatically better results that the 80-85% one -year survival now achieved, it 
is to be hoped that control of some of the long term complications will allow 
significant improvement in the five-year survival of approximately 60%. 
Accelerated arteriosclerosis provides a great challenge in cardiac 
transplantation with possible implications for progress in arteriosclerosis 
research in general. 
The possibility of improved immunosuppressive techniques allowing 
xenogranftng may further expand the options for those with end-stage cardiac 
disease. 
Paediatric cardiac transplantation is now being explored with early 
success, and this approach may become important in the future in the overall 
management of patients with server congenital heart disease. There may be a 
'window' of opportunity for transplanting infacts without the need for steroid or 
azathioprine therepy, allowing for nomal growth of these patients. 
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Whatever improvements are achieved in the management of cardiac 
transplant recipients, there are never going to be enough donor hearts to 
satisfy the demand, land equate supply of donor organs will continue to be a 
stimulus to the development of permanent left ventricular assist devices and 
artificial hearts to treat those patients who will be unable to receive biological 
cardiac replacement. The use of such devices as 'bridges' to cardiac 
transplantation has proved both successful and stimulating. 
2.22 CONCLUSION 
Heart transplantation remains an expensive option for a very limited no. 
of patients with irreversible heard disease and advanced CHF. There is not yet 
an exact description of which patients represent the best candidates for trans 
plantation. It is clear that the patient should be a younger patients with no other 
serious medical problem or complications that would offers the prognosis 
compounding the difficulties in obtaining suitable donor heart is the medico 
legal problem of the lack of universally accepted well defined criteria for brain 
health. 
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CHAPTER-3 
METHODOLOGY OF THE STUDY 
The present study aims at identification and description of some of the 
characteristics of the literature published in the field of "Heart Transplantation". 
Over the period of 3 years from 2000-2002 with a view to identifying place, 
year, language, subject areas, forms of document, country of origin were the 
document is published. 
It is well known that knowledge is growing at very fast rate. It is 
necessary that new work and new findings should be highlighted among the 
research scholars and others who are interested in them. So bibliometric study 
will help the librarian in the selection of literature in the field of "Heart 
transplantation". More precisely the main objectives of present study are. 
3.1 OBJECTIVES 
1. To know the most productive country on literature related to "Heart 
Transplantation". 
2. To know the eminent authors in the field of "Heart Transplantation". 
3. To know the rate of collaborative research. 
4. To know the language in which the most of literature on the subject has 
been published. 
5. To know the most used form of documents. 
6. To find out chronological distribution of items. 
7. To know the most productive journals in the filed of "Heart 
transplantation". 
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8. To identify tiie scattering of subjects. 
9. To check the validity of Bradford's, Lotka and Zipf s laws. 
3.2 HYPOTHESES 
1. Journals article may be the most used form of documents. 
2. Influence of group research may be seen in authorship "pattern of Heart 
Transplantation". 
3. Most of the articles may be written in English language in the field of 
"Heart Transplantation". 
4. There may be significant difference regarding geographical scattering of 
article on "Heart Transplantation". 
5. Chronological analysis of data may emerge as the reflection of 
acceleratory growth in the research out of the literature year by year. 
6. Bradford's law will be stand valid in the present study. 
7. Lotka's law will be valid in the present study. 
8. Zipf s law will be stand valid in the present study. 
3.3 METHODOLOGr 
The exponential growth of literature and rapid development of libraries, 
generated several evolutionary studies about the effectiveness and efficiency of 
information services. These studies led to the identification and application of 
appropriate qualitative measuring techniques known as Bibliometrics. 
Research in any area calls for systematic methodologies. The 
methodology for conducting the bibliometric study has been diagrammatically 
represented below: 
UKei£ocfo[o^tf ofl£e S/uJy 
Topic Selection 
T 
Selection of source document 
V 
Collection of data 
^' 
Preparation of Entries 
y ^  
Analysis 
t t t 
Subject Form wise Ranking of 
wise Distribution authors 
Distribution 
Language wise Country Year Ranking 
Distribution wise wise of 
Distribution Distribution periodicals 
(a) Topic Selection 
Heart is a vital part of a human body and is very essential and necessary 
to have it in good condition. Often man suffers from heart diseases and he is 
compelled to transplant his heart. But it is an risky affair. Though it is done in 
most parts of the world. Most of the people who are infected by this heart 
disease do not know about heart transplantation. There fore, this dissertation 
M^^ 
JKei£ocfo[o^y ofi£e SluJy 
may help in providing an insight into the different literature available on heart 
transplantation. 
(b) Selection of Source Document 
To undertake the bibliometric study on the literature of "Heart 
Transplantation" the Index Medicus v\/as found to be the most comprehensive 
and appropriate source of literature in the field of medical science. 
(c) Collection of Data 
The most important task was to select the document from which data 
has been drawn on the subject "Heart Transplantation" 2160 references from 
the 3 volumes of Index Medicus. i.e. from 2000 to 2002 was written on 5" X 3" 
square inches catalogue card. 
(d) Preparation of Entries 
By the help of Index Medicus data was collected on catalogue cards 5" X 
3". Each reference consisted of Information about author name, title, source, 
journal data, place, form and text language were noted on card. In other words 
a short bibliography was compiled on the cards. These were arranged and 
rearranged during analysis. 
(e) Analysis 
Next step, after preparation of entries, was to analyze the data that was 
collected from the source document. The total data collected on separate cards 
were arranged and rearranged in order to conduct the following studies. 
JICei£ocfofoyy of t£e Siudy 
(i) Subject wise Distribution 
This analysis has been done to know the scattering of literature of "Heart 
Transplantation" in other subject field. This analysis shows the interdisciplinary 
character of the subject field. The analysis has been done on the basis of field 
of periodicals publishing in the literature. The information about the subject field 
was obtained from Ulrich International periodical directory (35*^ & 38'" Ed.). 
(ii) From wise Distribution 
There are variety of forms of documents in which literature on "Heart 
Transplantation" are published. There are Articles, Research, Report, News 
letter etc. The analysis has been done to know the major forms of documents 
used for producing new information in the subject under study. These have 
been tabulated to find out most used source material. 
(iii) Ranking of Authors 
The researcher analyzed the authors on the basis of their frequency of 
occurrence i.e., in how many times an author occurs. This study has been 
conducted to know the eminent personalities in the field of "Heart 
Transplantation" Ranking of authors is done to identify the most productive 
contributions in the subject. For the purpose of ranking of authors, the research 
arranged them alphabetically, surname of each author is the basis for 
alphabetization. So all authors were retrieved, arranged and tabulated in the 
order of decreasing frequency of their contribution. 
(iv) Language wise Distribution of Items 
In this study an attempt has been made to analyze the language wise 
distribution of items. Since the source of document is of international level, and 
JICei£offotogy of i£e S/uJy 
have comprehensive coverage and articles are published in almost all 
languages of the world, so researcher analyzed the items language wise. In the 
index itself the language of original text is given. While collecting the data, 
noted according to the language and then arranged according to their rank, in 
order to know dominant language. 
(v) Geographical Scattering of Items 
This is done to determine the geographical scattering of items which 
studies the use pattern of research literature in the subject under the study. The 
information was collected from the Index Medicus for each items, which clearly 
give the place of origin of each item. The entries were grouped on the basis of 
their country of origin. 
(vi) Chronological Study 
In this analysis year of origin of item were studied to know how many 
items belong to a particular time period on the basis of frequency of items 
belonging to a particular year. The data was analyzed and tabulated to find the 
most productive year of items. 
(vii) Ranking or Periodicals 
The main objective of this study is to identify the core periodicals 
(journal) containing the research literature on "Heart Transplantation". To 
conduct this study, the items published in different periodicals were grouped 
together and conducted. It is necessary to know the most productive 
periodicals in the subject. 
CONCLUSION 
The last step oi this study is to conclude the findings of the study. 

CHAPTER- 4 
DATA ANALYSIS, INTERPRETATION AND 
REPRESENTATION 
Three volumes of Index Medicus for the year 2000-2002 were consulted 
for collecting the required data on the topic 'Heart Transplantation' The three 
volumes carried 2160 items on the subject. The data, so collected was 
analyzed as under: 
4.1 SUBJECT WISE DISTRIBUTION 
According to the law of scattering as explained earlier, most of the 
material on a subject appears in certain core journals. However a significant 
amount of literature is published in the journals of other related or marginal 
subject. The analysis pertaining to subject wise distribution of items has been 
done on the basis of subject field of journal, in which the literature on the 
subject is published. To find out the subject filed of journals "Ulrich 
International periodicals Directory, SS"" and 38^ Ed." have been consulted. 
Table No. 1 shows that the total number of 2160 items appearing in 185 
journals, which belong to 31 different subject. The most dominant subject area 
was found to be 'Medical Sciences Cardiovascular disease' in which 815 
items constitutes 37.73%. The second and third rank goes to 'Medial 
Sciences' with 410 items i.e., 18.98%, 'Medical Sciences - Surgery', with 
144 items i.e., 6.66% respectively. 
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Table No. 1 
SUBJECT WISE DISTRIBUTION 
s. 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Rank 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
11 
12 
12 
13 
14 
Subject Area 
Medical sciences -
cardiovascular diseases 
Medical Sciences 
Medial Sciences - Surgery 
Medical Sciences - Allergology & 
immunology 
Medical Sciences - Anaes 
thesiology 
Medical Sciences - Pharmacy 
and Pharmacology 
Medical Sciences - Psychiatry 
and Neurology 
Medical Sciences - Radiology & 
Nuclear Medicine 
Medical Sciences - Dermatology 
and Virology 
Medical Sciences - Experimental 
Medicine Laboratory techniques 
Biology - Biological Chemistry 
Psychology 
Medical Sciences -
Gastroenterology 
Medical Sciences - Abstracting 
bibliographies Statistics 
Medical Science - Pediatrics 
Medical Sciences - Nurses & 
Nursing 
Freq. 
Occurrence 
815 
410 
144 
125 
93 
90 
72 
70 
63 
45 
42 
42 
20 
20 
15 
14 
Freq.% 
37.73 
18.98 
6.66 
5.78 
4.30 
4.16 
3.33 
3.24 
2.91 
2.08 
1.94 
1.94 
0.92 
0.92 
0.69 
0.64 
Cumulativ 
e Freq. % 
37.73 
56.71 
63.37 
69.15 
73.45 
77.61 
80.94 
84.18 
87.09 
89.17 
91.11 
93.05 
93.97 
94.89 
95.58 
96.22 
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17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
15 
16 
16 
16 
17 
18 
18 
18 
18 
19 
19 
19 
19 
20 
20 
Medical Sciences - Urology and 
Nephrology 
Medical Sciences - Internal 
Medicine 
Biology - Cytology and Histology 
Medical Sciences - Sports 
Medicine 
Medical Sciences -
Chiropract6ive, Homeopathy, 
Osteopathy 
Medical Sciences -Respiratory 
disease 
Medical Sciences -
Communicable disease 
Medical Sciences -Physical 
Medicine and Rehabilitation 
Biology 
Medical Science - Endoerinology 
Biology - Physiology 
Medical Sciences - Orthopedics 
and Traumatology 
Medical Sciences - Dentistry 
Physics - Nuclear Physics 
Biology Geneties 
Total 
13 
9 
9 
9 
6 
4 
4 
4 
4 
3 
3 
3 
3 
2 
2 
2160 
0.60 
0.41 
0.41 
0.41 
0.27 
0.18 
0.18 
0.18 
0.18 
0.13 
0.13 
0.13 
0.13 
0.09 
0.09 
99.74 
96.82 
97.23 
97.64 
98.05 
98.32 
98.50 
98.68 
98.86 
99.04 
99.17 
99.30 
99.43 
99.56 
99.65 
99.74 
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Diagram No. 4 Subject wise Distribution of items 
37.73 
36.37 
Subjects 
• Medical Sciences-Cardiovascular Disease 
D Medical Sciences 
• Medical Sciences-Surgery 
• Others 
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4.2 FORM WISE DISTRIBUTION 
The analysis of table No. 2, shows that the literature on this subject are 
published are 8 different forms. It is evident from the data that 1828 items 
constituting 84.62% of the total data was published in the form Articles. This is 
followed by other forms like Letter with 154 items i.e. 7.13% and, News, 95 
items i.e., 4.40% occupied second and third position respectively. It may thus 
be concluded that the Article published in journals are most vital forms of media 
of communication among scientists belonging to the subject "Heart 
Transplantation". 
Table No. 2 
FORM WISE DISTRIBUTION 
S.No. 
1 
2 
3 
4 
5 
6 
7 
8 
Rank 
1 
2 
3 
4 
5 
6 
7 
8 
Name of the forms 
Article 
Letter 
News 
Comment 
Case Report 
Conference Proceedings 
Survey 
Review Literature 
Total 
Frequency 
1828 
154 
95 
41 
18 
10 
8 
6 
2160 
Frequency 
% 
84.62 
7.13 
4.40 
1.90 
0.83 
0.46 
0.37 
0.28 
99.99 
Cumulative 
Frequency % 
84.62 
91.75 
96.15 
98.05 
98.88 
99.34 
99.71 
99.99 
Z)<z/<z C^nafusis, 9n(erprelalion anJ^epresen/a/ion 
Diagram No. 5 Representing Bibliographic 
Form of Literature 
90 
80 
70 
60 
^ 
o^ "^^ O 
w 3 
•*-• re 
^ 0) 
4-> 
50 
40 
30 
20 
10 
0 
84.62 
7.13 
4.40 
Forms 
3.84 
(Articles H Letter DNews BOthers 
76 
2)a/a 9Inafi/sis, 9nlerpreiaiion anJOiepresen laiion 
4.3 RANKING OF AUTHORS 
The prime objective of this study is to find out the authors whose 
contribution is significant in the field of 'Heart Transplantation". For this purpose 
a ranking list of most productive authors has been prepared and presented in 
the table in order of their frequency of occurrence. It was found that 540 items 
i.e (25.00%) were written by single authors (i.e. only one contribution) and 
16.20 items (i.e 75.00%) were written by multiple author (i.e. more than one 
contribution). This shows that the present trend of research group oriented 
rather than single. The first five eminent authors in this field are Wang (SS), 
Niimi (M), Deng (MC), Aziz (T), Chen (W.) . ^v^' : i :^-^ ' '^ i : '^>S, 
Table No. 3 
i Ace. No... )*"! 
T V ^1' 
S. No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Rank 
1 
2 
3 
4 
5 
5 
6 
6 
6 
6 
6 
7 
7 
RANKING OF AUTHORSVV> 
Name of Authors 
Wang, S.S 
Niimi, M 
Deng, M.C 
Aziz, T 
Chen, W 
Qian, Z. 
Rose, M.L 
Weis, M. 
Lee, R.S 
Matsuda, H. 
Zhang, T. 
Almenar, L. 
Al-Riwas, 0.A 
Frequency" 
15 
12 
11 
9 
7 
7 
6 
6 
6 
6 
6 
5 
5 
"C-tntiniative 
Frequency 
15 
27 
38 
47 
54 
61 
67 
73 
79 
85 
91 
96 
101 
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14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
Bacal, F 
Ben-Gal, T 
Hosenpud, J.D 
Yamani, M.H 
Xu, H 
Kirsch, M 
Takayama, J. 
Step Kowaki, S.M 
Szabo, G 
Petting, K 
Allan, J.S 
Ankersmit, H.J 
Bishav, ES. 
Chiu, S.M 
Chin, C 
Forhi, A 
Guillon, B 
Hunt, S. 
He, H 
Holweg, C.T. 
John, R. 
Mohara, J 
Morguh, A 
Miniati, D.N. 
Muller, H.M. 
Koshiba, T. 
Ko. S 
Labarrere, C.A. 
U S . 
Leve, J. 
Wasowaka, B.A. 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
106 
111 
116 
121 
126 
131 
136 
141 
146 
151 
155 
159 
163 
167 
171 
175 
179 
183 
187 
191 
195 
199 
203 
207 
211 
215 
219 
223 
227 
231 
235 
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45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
8 
8 
8 
8 
8 
8 
8 
8 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
Wu, G. 
Tenderich, G. 
Trai. F.C. 
Nikolova 
Shirasungi, N. 
Suzuki, J. 
Reberi, A. 
Piq uard, F. 
Aranda, J.M 
Azzaur, M 
Blanche, C 
Baran, D.A. 
Braith, R.W. 
Bengel, P.M. 
Berman, M. 
Beranek, J.T 
Chan, S.M. 
Carrier, M. 
Cooper, D.C. 
Canver, C.C. 
Christiansen, S. 
Conroeds, V.M. 
Chong, A.S. 
Chu. S.H. 
Donofno, M.T. 
De Groot Kruseman, H.A. 
De Broux, E. 
Dotti, G. 
Dew, M.A. 
Erposito, S. 
Pukushinna, N. 
4 
4 
4 
4 
4 
4 
4 
4 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
239 
243 
247 
251 
255 
259 
263 
267 
270 
273 
276 
279 
282 
285 
288 
291 
294 
297 
300 
303 
306 
309 
312 
315 
318 
321 
324 
327 
330 
333 
336 
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11 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
Grande, A.M. 
Gao. W. 
Haga, M. 
Hancock, W.W. 
Hachida, M. 
Young, J.B. 
Xia, G.L 
Jung, F. 
Jahania, M.S. 
Martin, J. 
Marelli, D. 
Maksymowicz, M. 
Kocher, A.A. 
Kown, M.H. 
Kirklin, J.K. 
Kapoor 
Kawai, A 
Kirslin, J.K. 
Kown, M.H. 
Vriens, P.W. 
Laks, H. 
Link, T.M. 
Lim, G.Y. 
Wagher, F.D. 
Wilhelm, M.J. 
Tambuiar, A.R 
Teranishi, K. 
Taylor, Do. 
Smith, C.R 
Ogata, T. 
Otomo, N. 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
339 
342 
345 
348 
351 
354 
357 
360 
363 
366 
369 
372 
375 
378 
381 
384 
387 
390 
393 
396 
399 
402 
405 
408 
411 
414 
417 
420 
423 
426 
429 
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107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
9 
9 
9 
9 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
Oshima, K. 
Ritter, T. 
Robinson, L.A. 
Rerrault, LP 
Pieper, G.M. 
Parameshwar 
Patapov 
Polena, L. 
Alam, M. 
Aravot, D. 
Ardehali, A. 
Ankersmit, H.J 
Beckman, S.B. 
Boucek. M.M 
Behrens, D. 
Bann, C.C. 
Cantarovich, M. 
Costa, C.Y. 
Chien, C.V. 
Casiglia, E. 
Cafario, A.L. 
Copeland, J.G. 
Contin, B. 
Delgodo, J.F. 
Dellgren, G. 
Dorent, R. 
Dent, D.M. 
Docnst, T. 
Ewert, R. 
Fischer 
Firshbein, M.P 
3 
3 
3 
3 
3 
3 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
432 
435 
438 
441 
444 
447 
450 
453 
455 
457 
459 
461 
463 
465 
467 
469 
471 
473 
475 
477 
479 
481 
483 
485 
487 
489 
491 
493 
495 
497 
499 
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138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
167 
168 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
Feeley, B.T. 
Gock, H. 
Guo, L. 
Gregori, F. 
Grimm, H. 
Gasser, M. 
Zhai. Y. 
Zhu, T. 
Huang, C M . 
Hoehicke, E.M. 
Hausen, B. 
Hammer, C. 
Vamada, A. 
Vamaguchi, A. 
Iwata, A. 
Imai, M. 
Jones, B.U. 
Johnstom, D.R. 
Johanson, L. 
Jimenez, J. 
Jayakumar, J. 
Jiger, M.D. 
Milano, C.A. 
Marconi, C. 
Mehra, M.R. 
Marita, K. 
Kofer, R. 
Kocher, A.A. 
Kimball, P. 
Koglin, J. 
Keck, O.M 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
501 
503 
505 
507 
509 
511 
513 
515 
517 
519 
521 
523 
525 
527 
529 
531 
533 
535 
537 
539 
541 
543 
545 
547 
549 
551 
553 
555 
557 
559 
561 
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169 
170 
171 
172 
173 
174 
175 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
Konig, A. 
Kawacichi, M. 
Knosalla, C. 
Von Besouw, N.M. 
Lila, N. 
Livi, U. 
Legare, J.F. 
Lietz. K. 
Lamour, J.M. 
Liao, Y.H. 
Lacha, J. 
Loebe, M. 
Lemstrom, K.B. 
Uchita, S. 
Weston, L.E. 
Weigel, G. 
Tange, S. 
Tatou, E. 
Tasledo 
Narula, J. 
Nield. L.E. 
Nourani, F. 
Nagele, H. 
Sapar, G. 
Schiele, T.M. 
Singer, J.S. 
Savolainen, H. 
Suzuki, K. 
Saiura, A. 
Schlechta, B. 
Smolenski, R.T. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
563 
565 
567 
569 
571 
573 
575 
577 
579 
581 
583 
585 
587 
589 
591 
593 
595 
597 
599 
601 
603 
605 
607 
609 
611 
613 
615 
617 
619 
621 
623 
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200 
201 
202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
218 
219 
220 
2; 
^ 
21 
r 
1716 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
11 
^ r 
11 
Stoff, N. 
Sgrosso, J.L. 
Srivastava, R. 
Spurland, 1. 
Stoca, S.K. 
Okuda, T. 
Ohba, M. 
Ong, J.P 
Richter, M. 
Russell, P.S. 
Radoniavance, B. 
Rao, V. 
Pietra, B.A. 
Perz, M.G 
Pampsukian, S.V. 
Park, J.W. 
Putzke, J.D> 
Patel, A.R. 
Poston, R.S. 
Qi, Z. 
Grady. K.L. 
Almenar Sonet, L. 
^ r 
Dempsey, L.A. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1 
^ r 
1 
625 
627 
629 
631 
633 
635 
637 
639 
641 
643 
645 
647 
649 
651 
653 
655 
657 
659 
661 
663 
665 
666 
^ r 
2160 
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Note:-
220 Authors contributed 665 items, are those authors who contributed 
more than one paper. It means, total items contributed by these authors 2160 -
665 = 1495 No. of authors have contributed 1495 items by contributing 1 paper 
each. 
Therefore, total No. of authors = No. of authors 
Who contributed 1 paper = 220 + 1495 = 1715. 
DEGREE OF COLLABORATION 
Table: Single Vs. Multiple Author 
S. No. 
1 
2 
Author 
Single Author 
Multiple Author 
No. of papers 
540 
1620 
Percentage 
25.00% 
75.00% 
Subramanyam gave a formula for finding out the degree of collaboration 
as 
C = Nm 
Ns 
where C stands for degree of collaboration in any discipline. 
Nm stands for number of multiple authored papers and Ns stands for 
number of single authored papers. 
We have Nm = 1620 and Ns = 540 
So putting the value of Nm & Ns 
we get -
Nm C = 
Ns 
\Dala C^nafusisj 3nierprelalion ana Uiepresenlation 
540 
So degree of collaboration is about 3.00 we can show author's 
contribution with the help of table. 
The analysis of authorship patterns indicates that paper contributed by 
single author is 540 i.e. 25.00% of the total items and 1620 (75.00%) papers 
have been contributed by multiple authors. It was found that the tendency 
towards joint authorship was on an increase. This indicated that researchers 
normally prefer cooperative or group work. 
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Diagram No. 6 Representing the Authorship 
Pattern 
25% 
I Single Author H Multiple Author 
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4.4 LANGUAGE WISE DISTRIBUTION 
It is always useful for the researchers to know the language in which 
materials in their area of specialization is published. This type of study provides 
information about the most dominant language or languages in which the 
literature on the subject-' Heart Transplantation' is being produced. 
Table No. 4 shows the distribution of items according to the language of 
their publication out of a total 2160 items 1728 (80.00%) were published in 
English Language. The second and third rank goes to German and Spanish 
with 184 (8.52%) and 96 (4.44%) items respectively. 
TABLE NO. 4 
LANGUAGE WISE DISTRIBUTION 
s. 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Rank 
1 
2 
3 
4 
5 
6 
7 
8 
8 
8 
Name of Language 
English 
German 
Spanish 
French 
Portuguese 
Japanese 
Italian 
Slovak 
Polish 
Russian 
Frequency 
1728 
184 
96 
40 
34 
26 
14 
05 
05 
05 
Frequency 
% 
80.00 
8.52 
4.44 
1.85 
1.57 
1.20 
0.65 
0.28 
0.23 
0.23 
Cumulative 
Frequency % 
80.00 
88.52 
92.96 
94.81 
96.38 
97.58 
98.23 
98.51 
98.74 
98.97 
Q)ala C^nafysi's, 3nierpreialion and[Represenlalion 
11 
12 
13 
14 
15 
16 
9 
9 
10 
10 
10 
10 
Dutch 
Chinese 
Norwegian 
Hungarian 
Czech 
Danish 
Total 
04 
04 
03 
03 
03 
03 
2160 
0.23 
0.18 
0.14 
0.14 
0.14 
0.14 
99.94 
99.20 
99.38 
99.52 
99.66 
99.80 
99.94 
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Diagram No. 7 Representing Language wise Distribution 
of items 
80.00 
70.00-
60.00 
^ 
o^ 
O 
_l 
50.00 
40.00 
30.00 
20.00 
10.00 
0.00 
80.00 
Languages 
I English •German 13 Spanish • Others 
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4.5 GEOGRAPHICAL DISTRIBUTION 
Table No. 5 shows list of 26 countries upto 16 rank on literature "Heart 
Transplantation." It was observed that 44.25% of total number of journal were 
published from USA only. UK and Germany produced 26.38% and and 6.48% 
journal respectively. It was found that literary output of USA is more than other 
countries. In the ranking list USA accounted for 956 of total items i.e., 44.25%. 
Table No. 5 
GEOGRAPHICAL DISTRIBUTION 
S. No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Rank 
1 
2 
3 
4 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Name of Country 
USA 
UK 
Germany 
Japan 
Denmark 
France 
Netherlands 
Italy 
Spain 
Switzerland 
Canada 
South Africa 
Poland 
Frequency of 
Occurrence 
956 
570 
140 
90 
90 
83 
62 
33 
21 
19 
11 
10 
9 
% age 
44.25 
26.38 
6.48 
4.16 
4.16 
3.84 
2.87 
1.52 
0.97 
0.87 
0.50 
0.46 
0.41 
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14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
12 
12 
13 
14 
15 
15 
15 
15 
15 
15 
15 
15 
16 
Austria 
Slovakia 
Mexio 
Ireland 
Norway 
Puerto Rico 
New Zealand 
Chile 
India 
Czech Republic 
China 
Israel 
Australia 
Total 
9 
9 
7 
6 
4 
4 
4 
4 
4 
4 
4 
4 
3 
2160 
0.41 
0.41 
0.32 
0.27 
0.18 
0.18 
0.18 
0.18 
0.18 
0.18 
0.18 
0.18 
0.13 
99.85 
